Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.
By M. Egger, M. May, G. Chêne, A. Phillips, B. Ledergerber, F. Dabis, D. Costagliola, A. Monforte, F. Wolf, P. Reiss and 9 more. The Lancet, 2002
1,651 citations recorded by the source corpus.
Subfields: Infectious Diseases, Virology
View Paper: https://www.semanticscholar.org/paper/798c8e183057abf1205b144a46619af4ef879b5e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007, neutral): “The severity of immunodeficiency at baseline ranged from not measureable to very severe, and viral load from undetectable to extremely high’’ [215].”
- Patient Retention in Antiretroviral Therapy Programs Up to Three Years on Treatment in Sub-Saharan Africa, 2007–2009: Systematic review (2010, background): “ART has clearly been shown to be effective in reducing mortality among those who remain in treatment and adhere to therapy (Egger et al. 2002; Coetzee et al. 2004; Ivers et al. 2005; Laurent et al. 2005; Lawn et al. 2005), but under programmatic conditions, not all patients remain in treatment.”
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic Review (2007, background): “’’ Given that the long-term prognosis of ART patients is inversely related to starting CD4þ T cell counts [16,17], an additional issue to consider is the low median starting CD4þ cell counts reported by every one of the studies in this analysis.”
- Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa (2008, result): “In contrast to data from high-income settings [2], increasing age was associated with higher mortality risk in only one cohort [8].”
- Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa (2004, background): “The benefits of antiretroviral therapy (ART) at an individual level are incontrovertible [1,2].”